Search results for "Neoplastic"

showing 10 items of 2901 documents

CD133 Expression Is Not Synonymous to Immunoreactivity for AC133 and Fluctuates throughout the Cell Cycle in Glioma Stem-Like Cells.

2015

A transmembrane protein CD133 has been implicated as a marker of stem-like glioma cells and predictor for therapeutic response in malignant brain tumours. CD133 expression is commonly evaluated by using antibodies specific for the AC133 epitope located in one of the extracellular domains of membrane-bound CD133. There is conflicting evidence regarding the significance of the AC133 epitope as a marker for identifying stem-like glioma cells and predicting the degree of malignancy in glioma cells. The reasons for discrepant results between different studies addressing the role of CD133/AC133 in gliomas are unclear. A possible source for controversies about CD133/AC133 is the widespread assumpt…

G2 PhaseCell divisionlcsh:MedicineEpitopeS PhaseFlow cytometryEpitopes03 medical and health sciences0302 clinical medicinefluids and secretionsAntigens CDCell Line TumorGliomamedicineHumansAC133 Antigenlcsh:ScienceneoplasmsGlycoproteins030304 developmental biologychemistry.chemical_classification0303 health sciencesMultidisciplinarybiologymedicine.diagnostic_testlcsh:RGliomaCell cyclemedicine.diseaseCaco-2 cells; Cell cycle and cell division; Cell membranes; Cell staining; DAPI staining; Flow cytometry; Glioma cells; Membrane proteinsTransmembrane proteinCell biologyGene Expression Regulation Neoplasticcarbohydrates (lipids)chemistry030220 oncology & carcinogenesisembryonic structuresNeoplastic Stem Cellsbiology.proteincardiovascular systemlcsh:QCaco-2 CellsAntibodyPeptidesGlycoproteinCell DivisionResearch Article
researchProduct

Apoptosis induced in hepatoblastoma HepG2 cells by the proteasome inhibitor MG132 is associated with hydrogen peroxide production, expression of Bcl-…

2002

This report is focused on the apoptotic effect induced by MG132, an inhibitor of 26S proteasome, in human hepatoma HepG2 cells. The results were compared with those obtained with non-transformed human Chang liver cells. MG132 reduced the viability of HepG2 cells in a time- and dose-dependent manner. The effect was in tight connection with the induction of apoptosis, as indicated by fluorescence microscopy and cytometric analysis, and was accompanied by a remarkable increase in the production of H2O2 and a reduction in mitochondrial transmembrane potential (Deltapsim). In addition cell death was prevented by antioxidants such as GSH, N-acetylcysteine or catalase. Western blot analysis showed…

G2 PhaseHepatoblastomaCancer ResearchProgrammed cell deathProteasome Endopeptidase ComplexMG132Time FactorsCell SurvivalLeupeptinsPoly ADP ribose polymeraseBlotting Westernbcl-X ProteinMitosisCaspase 3Antineoplastic AgentsApoptosismacromolecular substancesMembrane Potentialschemistry.chemical_compoundCytosolMultienzyme ComplexesMG132medicineTumor Cells CulturedHumansCaspasebiologyCaspase 3Cytochrome cCell CycleLiver NeoplasmsHydrogen PeroxideFlow CytometryMolecular biologyMitochondriaEnzyme ActivationCysteine EndopeptidasesOxidative StressOncologyBiochemistrychemistryProto-Oncogene Proteins c-bcl-2ApoptosisCaspasesbiology.proteinProteasome inhibitormedicine.drug
researchProduct

Design, synthesis, and biological evaluation of thiophene analogues of chalcones.

2008

Chalcones are characterized by possessing an enone moiety between two aromatic rings. A series of chalcone-like agents, in which the double bond of the enone system is embedded within a thiophene ring, were synthesized and evaluated for antiproliferative activity and inhibition of tubulin assembly and colchicine binding to tubulin. The replacement of the double bond with a thiophene maintains antiproliferative activity and therefore must not significantly alter the relative conformation of the two aryl rings. The synthesized compounds were found to inhibit the growth of several cancer cell lines at nanomolar to low micromolar concentrations. In general, all compounds having significant anti…

G2 PhaseModels MolecularDouble bondStereochemistryClinical BiochemistryPharmaceutical ScienceEtherAntineoplastic Agentsmacromolecular substancesThiophenesBiochemistryChemical synthesischemistry.chemical_compoundMiceStructure-Activity RelationshipChalconesTubulinCell Line TumorDrug DiscoveryThiopheneMoietyAnimalsHumansMolecular BiologyCell Proliferationchemistry.chemical_classificationBinding SitesbiologyDose-Response Relationship DrugMolecular StructureArylOrganic ChemistryCell CycleBrainStereoisomerismTubulin ModulatorsTubulinchemistryDrug Designbiology.proteinMolecular MedicineCattleDrug Screening Assays AntitumorColchicineK562 CellsEnoneCell DivisionHeLa CellsBioorganicmedicinal chemistry
researchProduct

Comparison of the chemopreventive efficacies of garlic powders with different alliin contents against aflatoxin B1 carcinogenicity in rats

2004

Garlic (Allium sativum) is well known for its beneficial effects on health and particularly for its chemopreventive potential against cancer. The present study was designed to compare the chemopreventive efficacies of several garlic powders with various levels of alliin, a precursor of active sulfur compounds. For this purpose we used the medium-term hepatocarcinogenesis protocol (resistant hepatocyte model), which allows the detection of preneoplasic foci expressing the placental form of glutathione S-transferase (GST-P) as an end-point. Rats were fed diets containing three garlic powders (5% of the diet) with various alliin contents for 3 weeks. Garlic powders were obtained from bulbs gro…

GARLIC POWDERMale[SDE] Environmental SciencesCancer ResearchAflatoxinAflatoxin B1[SDV]Life Sciences [q-bio]Antineoplastic AgentsAlliinChemoprevention03 medical and health scienceschemistry.chemical_compound0302 clinical medicinefoodLiver Neoplasms ExperimentalCytochrome P-450 CYP1A1IngestionAnimalsFood scienceCysteineGlucuronosyltransferaseRats WistarGarlicAnticarcinogenCarcinogenComputingMilieux_MISCELLANEOUS030304 developmental biologyGlutathione Transferase2. Zero hunger0303 health sciencesfood and beveragesGeneral MedicineGlutathioneAllium sativumCANCERfood.food3. Good healthDietRats[SDV] Life Sciences [q-bio]chemistryBiochemistry030220 oncology & carcinogenesis[SDE]Environmental SciencesRATPowdersCARCINOGENESEPrecancerous Conditions
researchProduct

Galectin-3 Impairment of MYCN-Dependent Apoptosis-Sensitive Phenotype Is Antagonized by Nutlin-3 in Neuroblastoma Cells

2012

MYCN amplification occurs in about 20-25% of human neuroblastomas and characterizes the majority of the high-risk cases, which display less than 50% prolonged survival rate despite intense multimodal treatment. Somehow paradoxically, MYCN also sensitizes neuroblastoma cells to apoptosis, understanding the molecular mechanisms of which might be relevant for the therapy of MYCN amplified neuroblastoma. We recently reported that the apoptosis-sensitive phenotype induced by MYCN is linked to stabilization of p53 and its proapoptotic kinase HIPK2. In MYCN primed neuroblastoma cells, further activation of both HIPK2 and p53 by Nutlin-3 leads to massive apoptosis in vitro and to tumor shrinkage an…

Galectin 3Cancer TreatmentGene Dosagelcsh:MedicineApoptosisProtein-Serine-Threonine KinaseBiochemistryPiperazineschemistry.chemical_compoundNeuroblastoma0302 clinical medicineMolecular Cell BiologyBasic Cancer ResearchSignaling in Cellular Processeslcsh:ScienceEnergy-Producing OrganellesApoptotic SignalingNuclear ProteinOncogene Proteins0303 health sciencesN-Myc Proto-Oncogene ProteinMultidisciplinaryCell DeathImidazolesOncogene ProteinNuclear ProteinsTransfectionNutlin3. Good healthGene Expression Regulation NeoplasticProtein TransportCell killingPhenotypeOncologyGalectin-3030220 oncology & carcinogenesisGene Knockdown TechniquesMedicineResearch ArticleSignal TransductionHumanBiologyBioenergeticsProtein Serine-Threonine KinasesN-Myc Proto-Oncogene ProteinModels Biological03 medical and health sciencesNeuroblastomaCell Line TumormedicineHumansBiologyImidazolePiperazineneoplasms030304 developmental biologylcsh:RGene AmplificationChemotherapy and Drug Treatmentmedicine.diseasechemistryCell cultureApoptosisPediatric OncologyCytoprotectionGene Knockdown TechniqueCancer researchlcsh:QTumor Suppressor Protein p53Carrier ProteinsCarrier ProteinDNA Damage
researchProduct

Highly potent artemisinin-derived dimers and trimers: Synthesis and evaluation of their antimalarial, antileukemia and antiviral activities

2015

New pharmaceutically active compounds can be obtained by modification of existing drugs to access more effective agents in the wake of drug resistance amongst others. To achieve this goal the concept of hybridization was established during the last decade. We employed this concept by coupling two artemisinin-derived precursors to obtain dimers or trimers with increased in vitro activity against Plasmodiumfalciparum 3D7 strain, leukemia cells (CCRF-CEM and multidrug-resistant subline CEM/ADR5000) and human cytomegalovirus (HCMV). Dimer 4 (IC50 of 2.6 nM) possess superior antimalarial activity compared with its parent compound artesunic acid(3) (IC50 of 9.0 nM). Dimer5 and trimers6 and 7 disp…

GanciclovirStereochemistrymedicine.medical_treatmentDimerClinical BiochemistryPharmaceutical ScienceDihydroartemisininAntiviral AgentsBiochemistryAntimalarialschemistry.chemical_compoundDrug DiscoverymedicineHumansPotencyDoxorubicinArtemisininMolecular BiologyIC50Molecular StructureOrganic ChemistryAntineoplastic Agents PhytogenicCombinatorial chemistryArtemisininsIn vitrochemistryMolecular Medicinemedicine.drugBioorganic & Medicinal Chemistry
researchProduct

Design of antitumor drugs targeting c-kit receptor by a new mixed ligand-structure based method

2020

An important challenge, in the medicinal chemistry field, is the research of novel forceful drugs to overcome tumor-acquired resistance. The c-Kit tyrosine kinase receptor (TKR) represents a suitable target for the carcinogenesis control of gastro-intestinal stromal (GIST), leukemia, and mastocytosis tumors; nevertheless, several hotspot mutations of the protein limit the efficacy of a few clinical administered TKRs inhibitors. In this study, a new in silico protocol based on ligand and structure-based combined method is proposed, with the aim to identify a set of new c-Kit inhibitors able to complex c-Kit mutated proteins. A recent and freely available web-server DRUDIT is used for the lig…

Gastrointestinal Stromal TumorsIn silicoAntineoplastic AgentsComputational biologyDrug resistanceIn silico protocolsmedicine.disease_causeLigandsReceptor tyrosine kinase03 medical and health sciences0302 clinical medicineDRUDIT web-serverc-KitMaterials ChemistrymedicineHumansPhysical and Theoretical ChemistryProtein Kinase InhibitorsSpectroscopy030304 developmental biology0303 health sciencesbiologyChemistryLigandMixed ligandmedicine.diseaseComputer Graphics and Computer-Aided DesignLeukemiaProto-Oncogene Proteins c-kitDocking (molecular)Drug Resistance Neoplasm030220 oncology & carcinogenesisDrug resistanceMutationMolecular dockingbiology.proteinCarcinogenesis
researchProduct

Influence ofKi-ras-driven oncogenic transformation on the protein network of murine fibroblasts

2007

Ki-ras gene mutations that specifically occur in codons 12, 13 and 61 are involved in the carcinogenesis of acute myeloid leukemia, melanoma and different carcinomas. In order to define potential mutation-specific therapeutic targets, stable transfectants of NIH3T3 cells carrying different Ki-ras4B gene mutations were generated. Wild type Ki-ras transformants, mock transfectants and parental cells served as controls. These in vitro model systems were systematically analyzed for their protein expression pattern using two-dimensional gel electrophoresis followed by mass spectrometry and/or protein sequencing. Using this approach, a number of target molecules that are differentially but coordi…

Gel electrophoresismedicine.diagnostic_testWild typeFibroblastsBiologyGene mutationTransfectionmedicine.disease_causeProteomicsBiochemistryMolecular biologyMiceCell Transformation NeoplasticWestern blotHeat shock proteinNIH 3T3 Cellsras ProteinsmedicineAnimalsMitogen-Activated Protein KinasesCarcinogenesisMolecular BiologyGeneSignal TransductionPROTEOMICS
researchProduct

Gene Expression Analysis Uncovers Similarity and Differences Among Burkitt Lymphoma Subtypes.

2011

Abstract Abstract 2494 Background. Burkitt lymphoma (BL) is currently listed in the WHO classification of lymphoid tumors as a single genetic and morphological entity with variation in clinical presentation. In particular, three clinical subsets of BL are recognized: endemic (eBL), sporadic (sBL) and immunodeficiency associated (ID-BL). Each affects different populations and can present with different features. So far, possible differences in their gene expression profiles (GEP) have not been investigated. In this study we aimed to 1) assess whether BL subtypes present with differences in their GEP; 2) investigate the relationship of the different BL subtypes with the non-neoplastic cellula…

Gene Expression Profiles; burkitt lymphomaGene expression analysieducationTransplantation HeterologousImmunologyMice NudeBiologyburkitt lymphomaBiochemistryBurkitt lymphoma.Micehemic and lymphatic diseasesCell Line TumormedicineAnimalsCluster AnalysisHumansRegulation of gene expressionGeneticsGene Expression ProfilesGENE EXPRESSION PROFILEMicroarray analysis techniquesGene Expression ProfilingGerminal centerCell BiologyHematologymedicine.diseaseMicroarray AnalysisPhenotypeLymphomaGene expression profilingTransplantationGene Expression Regulation NeoplasticPhenotypeBurkitt's lymphomaNeoplasm TransplantationGene expression analysis;Burkitt lymphoma.
researchProduct

miR-486-5p expression is regulated by DNA methylation in osteosarcoma.

2022

Abstract Background Osteosarcoma is the most common primary malignant tumour of bone occurring in children and young adolescents and is characterised by complex genetic and epigenetic changes. The miRNA miR-486-5p has been shown to be downregulated in osteosarcoma and in cancer in general. Results To investigate if the mir-486 locus is epigenetically regulated, we integrated DNA methylation and miR-486-5p expression data using cohorts of osteosarcoma cell lines and patient samples. A CpG island in the promoter of the ANK1 host gene of mir-486 was shown to be highly methylated in osteosarcoma cell lines as determined by methylation-specific PCR and direct bisulfite sequencing. High methylati…

Gene Expression Regulation NeoplasticMicroRNAsOsteosarcomaCell Line TumorGeneticsHumansBone NeoplasmsDNA MethylationBiotechnologyCell ProliferationEpigenesis GeneticBMC genomics
researchProduct